ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3Y8X563
Stock Name / FundiShares S&P 500 GBP Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIGUS(GBX) LSE
ETF TickerIGUS.LS(GBX) CXE
ETF TickerIGUS.L(GBP) LSE

Holdings detail for LLY

Stock Name
Ticker()

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 15:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 14:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 06:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 03:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 01:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 12:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 15:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 13:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 04:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 09:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 09:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 06:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 13:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 06:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 07:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 15:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 12:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 14:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 06:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 19:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 11:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 05:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 11:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 15:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 05:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 16:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 06:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 20:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 18:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 18:55:00

iShares S&P 500 GBP Hedged UCITS ETF (Acc) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2026-06-04 (Thursday)19,600USD 16,405,915LLY holding increased by 669609USD 16,405,9150USD 669,609 USD 837.036 USD 802.873
2026-06-03 (Wednesday)19,600USD 15,736,306LLY holding increased by 254888USD 15,736,3060USD 254,888 USD 802.873 USD 789.868
2026-06-02 (Tuesday)19,600USD 15,481,418LLY holding decreased by -303602USD 15,481,4180USD -303,602 USD 789.868 USD 805.358
2026-06-01 (Monday)19,600USD 15,785,020LLY holding decreased by -282342USD 15,785,0200USD -282,342 USD 805.358 USD 819.763
2026-05-29 (Friday)19,600LLY holding decreased by -170USD 16,067,362LLY holding decreased by -519389USD 16,067,362-170USD -519,389 USD 819.763 USD 838.986
2026-05-28 (Thursday)19,770USD 16,586,751LLY holding increased by 632857USD 16,586,7510USD 632,857 USD 838.986 USD 806.975
2026-05-27 (Wednesday)19,770USD 15,953,894LLY holding increased by 303985USD 15,953,8940USD 303,985 USD 806.975 USD 791.599
2026-05-26 (Tuesday)19,770USD 15,649,909LLY holding increased by 55308USD 15,649,9090USD 55,308 USD 791.599 USD 788.801
2026-05-25 (Monday)19,770USD 15,594,601LLY holding decreased by -78939USD 15,594,6010USD -78,939 USD 788.801 USD 792.794
2026-05-22 (Friday)19,770USD 15,673,540LLY holding increased by 318494USD 15,673,5400USD 318,494 USD 792.794 USD 776.684
2026-05-21 (Thursday)19,770USD 15,355,046LLY holding increased by 362630USD 15,355,0460USD 362,630 USD 776.684 USD 758.342
2026-05-20 (Wednesday)19,770USD 14,992,416LLY holding decreased by -84506USD 14,992,4160USD -84,506 USD 758.342 USD 762.616
2026-05-19 (Tuesday)19,770USD 15,076,922LLY holding increased by 492922USD 15,076,9220USD 492,922 USD 762.616 USD 737.683
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00B3Y8X563

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-05-29SELL-1701,128.4901,089.005 1,092.954 -185,802 665.13 Loss of -72,731 on sale
2026-04-30BUY531945.500896.800 901.670 478,787 659.46
2026-04-10BUY167963.940935.540 938.380 156,709 659.17
2026-03-31SELL-349924.144892.140 895.340 -312,474 657.83 Loss of -82,891 on sale
2026-03-23SELL-91 680.251* 657.48 Profit of 59,830 on sale
2026-03-09SELL-171 752.839* 655.40 Profit of 112,074 on sale
2026-02-27SELL-319 782.469* 653.52 Profit of 208,473 on sale
2026-01-30BUY3931,048.5691,020.000 1,022.857 401,983 648.42
2026-01-05BUY1711,085.3801,033.380 1,038.580 177,597 639.73
2025-12-31BUY2751,083.3701,074.430 1,075.324 295,714 638.37
2025-12-31BUY2751,083.3701,074.430 1,075.324 295,714 638.37
2025-12-01BUY1681,084.1501,055.000 1,057.915 177,730 625.31
2025-11-28BUY1351,098.8701,067.800 1,070.907 144,572 624.44
2025-10-31SELL-420869.910834.950 838.446 -352,147 611.75 Loss of -95,211 on sale
2025-10-27SELL-171826.410826.420 826.419 -141,318 611.51 Loss of -36,750 on sale
2025-09-29BUY171726.510727.860 727.725 124,441 612.19
2025-09-24BUY171741.850746.940 746.431 127,640 613.39
2025-08-29BUY328732.580737.420 736.936 241,715 618.37
2025-07-31SELL-665740.070766.450 763.812 -507,935 618.73 Loss of -96,477 on sale
2025-07-18SELL-174771.710775.960 775.535 -134,943 620.36 Loss of -27,001 on sale
2025-07-03BUY174780.670783.550 783.262 136,288 622.79
2025-06-30BUY528779.530785.000 784.453 414,191 623.51
2025-06-26BUY169795.120798.800 798.432 134,935 624.22
2025-06-12BUY169812.030818.560 817.907 138,226 627.25
2025-05-13BUY169746.060759.500 758.156 128,128 641.70
2025-04-30BUY629898.950902.500 902.145 567,449 645.81
2025-04-23SELL-163829.420846.010 844.351 -137,629 645.58 Loss of -32,399 on sale
2025-04-16BUY163734.900756.300 754.160 122,928 647.48
2025-04-08BUY163726.240763.500 759.774 123,843 652.88
2025-03-31BUY517825.910828.010 827.800 427,973 655.75
2025-03-17BUY158824.760829.000 828.576 130,915 657.23
2025-03-03BUY158929.720935.630 935.039 147,736 655.75
2025-02-28BUY134920.630921.220 921.161 123,436 654.51
2025-02-03BUY157810.430817.960 817.207 128,302 637.97
2025-01-31SELL-102811.080827.350 825.723 -84,224 637.61 Loss of -19,188 on sale
2025-01-30BUY158823.230824.620 824.481 130,268 637.04
2025-01-02SELL-271778.070787.000 786.107 -213,035 637.06 Loss of -40,392 on sale
2024-12-06BUY161826.710841.000 839.571 135,171 637.90
2024-11-29SELL-214795.350800.330 799.832 -171,164 637.42 Loss of -34,756 on sale
2024-10-31SELL-707829.740853.500 851.124 -601,745 688.23 Loss of -115,167 on sale
2024-10-25BUY170892.700900.960 900.134 153,023 695.75
2024-10-22BUY340909.150911.120 910.923 309,714 696.97
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy